Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer.
Ychou M, Pelegrin A, Faurous P, Robert B, Saccavini JC, Guerreau D, Rossi JF, Fabbro M, Buchegger F, Mach JP, Artus JC. Ychou M, et al. Among authors: saccavini jc. Int J Cancer. 1998 Feb 9;75(4):615-9. doi: 10.1002/(sici)1097-0215(19980209)75:4<615::aid-ijc20>3.0.co;2-6. Int J Cancer. 1998. PMID: 9466665 Free article. Clinical Trial.
Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer.
Ychou M, Azria D, Menkarios C, Faurous P, Quenet F, Saint-Aubert B, Rouanet P, Pèlegrin M, Bascoul-Mollevi C, Guerreau D, Saccavini JC, Mach JP, Artus JC, Pèlegrin A. Ychou M, et al. Among authors: saccavini jc. Clin Cancer Res. 2008 Jun 1;14(11):3487-93. doi: 10.1158/1078-0432.CCR-07-4698. Clin Cancer Res. 2008. PMID: 18519781 Free PMC article. Clinical Trial.
Potential contribution of 131I-labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: pretherapeutic study with dose recovery in resected tissues.
Ychou M, Ricard M, Lumbroso J, Rougier P, Mach JP, Buchegger F, Saccavini JC, Lasser P, Elias D, Eschwege F, et al. Ychou M, et al. Among authors: saccavini jc. Eur J Cancer. 1993;29A(8):1105-11. doi: 10.1016/s0959-8049(05)80297-7. Eur J Cancer. 1993. PMID: 8518021
[Immunotargeting of tumors: state of the art and prospects in 2000].
Pèlegrin A, Xavier F, Barbet J, Bartholeyns J, Baty D, Buchegger F, Chatal JF, Dufief F, Gurreau D, Gruaz-Guyon A, Lamotte D, Leserman L, Mach JP, Robert B, Saccavini JC, Teillaud JL, Teulon I. Pèlegrin A, et al. Among authors: saccavini jc. Bull Cancer. 2000 Nov;87(11):777-91. Bull Cancer. 2000. PMID: 11125287 Free article. Review. French.
37 results